The World Health Organization says a clinical trial has started in the Democratic Republic of Congo to test two potential treatments for the Bundibugyo species of Ebola, which has been driving an outbreak in the country’s northeastern provinces. WHO reports that there are currently no approved vaccines or treatments for this rare strain. WHO figures cited in the coverage indicate 1,406 confirmed cases and 438 confirmed deaths in the DRC, with 208 recoveries reported. WHO Director-General Tedros Adhanom Ghebreyesus says the trial begins with the enrollment of the first patient and evaluates the monoclonal antibody MBP134 and the antiviral drug remdesivir, tested alone and in combination. The study is conducted by the DRC’s National Institute for Biomedical Research with support from partners including the WHO. The organization says participants receive comprehensive supportive care and close follow-up during the trial, and that efforts are underway to ensure access to the two drugs if they are found safe and effective.
WHO begins trial of two potential treatments for Bundibugyo Ebola in DR Congo
The World Health Organization says a clinical trial has started in the Democratic Republic of Congo to test two potential treatments for the Bundibugyo species of Ebola, which has been driving an outb...
- A WHO-led effort begins a clinical trial in DR Congo for the Bundibugyo strain of Ebola.
- The trial tests monoclonal antibody MBP134 and the antiviral drug remdesivir, alone and in combination.
- The trial is conducted by DR Congo’s National Institute for Biomedical Research with support from partners including WHO.
- WHO says patients in the trial receive comprehensive supportive care and close follow-up.
- WHO reports 1,406 confirmed cases and 438 confirmed deaths in the DRC for the outbreak at the time of the announcement.
A clinical trial for two potential Ebola treatments, MBP134 and remdesivir, has commenced in DR Congo to combat the deadly Bundibugyo strain. Learn more ab Read More: https://punchng.com/trial-of-potential-ebola-treatments-begins-in-dr-congo-who/
1 hour agoClinical testing of two antiviral therapy approaches against Ebola is beginning in the Democratic Republic of Congo, the World Health Organisation says.
1 hour agoClinical testing of two antiviral therapy approaches against Ebola is beginning in the Democratic Republic of Congo, the World Health Organisation says.
1 hour agoGENEVA, Switzerland (AFP) — The trial of two potential treatments for the Bundibugyo species of Ebola behind the deadly outbreak in the DR Congo began in the country on Thursday, the World Health Organization said. There are no approved vaccines or treatments for the rare strain which has been spreading in the northeastern provinces of the Democratic Republic of Congo. There have been 1,406 confirmed cases and 438 confirmed deaths in the DRC, while 208 people have recovered from the virus, according to figures from the WHO. "Today, the clinical trial of two therapeutics began, with the enrolment of the first patient," with the trial evaluating the monoclonal antibody MBP134 and the antiviral drug remdesivir, alone and in combination, WHO chief Tedros Adhanom Ghebreyesus told reporters. He said the study was being conducted by the DRC's National Institute for Biomedical Research, backed up by partners including the WHO. "Patients who enroll in the trial will receive comprehensive supportive care and close follow-up," Tedros insisted. "We are also working to ensure they have access to the two drugs should they prove safe and efficacious in the trial."
3 hours ago
Police investigate British men suspected of drugging partners for others to rape them
Police are investigating multiple allegations involving British men suspected of drugging their wives or partners so tha...
Craig Ferguson returns home after 3,000-mile US walk raising over £1m for charity
Craig Ferguson, a Scottish football fan often described as a “Tartan Army” supporter, returns home after completing a lo...
DUP leader says review into Gavin Robinson Donaldson behaviour will be unprecedented
The DUP’s Gavin Robinson says a review into Donaldson’s behaviour will be “unprecedented.” Speaking publicly, Robinson s...